Han Chang,
Principal Scientist
Dr. Han Chang is currently leading cancer genomics and nextgen sequencing efforts at Bristol-Myers Squibb Co. He has extensive experience of applying genomics technologies and bioinformatics to oncology and immunology drug discovery and development. Dr. Han Chang received Ph.D. from Harvard University and completed postdoctoral training at Stanford University.
|
|
|
